CPIX News | Roxom Stocks

1 BTC

- USD

Loading market data...

Mkt Cap

$113.0M

Volume

85.64K

Next Earnings

November 3rd

Chart Financials Earnings News About Dividends Insider Filings

Hepatic Encephalopathy Market Analysis and Forecast, 2025-2035 - Key Players Shape the Market with Strategic Partnerships and Innovative TherapiesGlobal hepatic encephalopathy market expected to grow steadily, driven by rising liver disease prevalence, improved diagnostics, and novel therapies, despite challenges like high treatment costs and underdiagnosis.GlobeNewswire Inc. · Nov 27, 2025

RedHill Biopharma Receives Nasdaq Staff Determination NotificationRedHill Biopharma received a Nasdaq Staff Determination letter indicating non-compliance with minimum stockholders' equity requirements. The company plans to appeal the determination and believes its recent transaction with Cumberland Pharmaceuticals has improved its equity position.Benzinga · Oct 22, 2025

Diffuse Cutaneous Systemic Sclerosis Market Forecast: Opportunities and Growth Trends Upto 2034 | DelveInsightThe diffuse cutaneous systemic sclerosis (dcSSc) market is evolving towards targeted therapies addressing fibrosis and immune modulation, with promising drug candidates from multiple pharmaceutical companies targeting various pathogenic pathways.GlobeNewswire Inc. · Oct 6, 2025

Duchenne Muscular Dystrophy Market to Witness Significant Expansion During the Forecast Period (2025–2034) Amidst Advances in Gene Therapy and Novel Drug Approvals | DelveInsightThe Duchenne muscular dystrophy market is experiencing steady growth driven by advancements in gene therapies, exon-skipping drugs, and emerging treatment options. Key players are expanding pipelines with novel therapies in late-stage clinical trials, with potential market transformation expected between 2025-2034.GlobeNewswire Inc. · Jul 28, 2025

Dilated Cardiomyopathy Market Witnesses Robust Growth During the Study Period (2020–2034) Amid Advancements in Cardiovascular Therapies | DelveInsightThe dilated cardiomyopathy market is experiencing steady growth, driven by rising prevalence of heart failure, improved diagnostic techniques, and advancements in genetic testing. Increasing R&D investment in gene therapies and novel drug candidates is expanding treatment options.GlobeNewswire Inc. · Jun 5, 2025

Evolving Landscape of Cardiology Segment: Key Market Insights of Latest Published Rare Cardiovascular Diseases Report — Giant-Cell Arteritis, Pulmonary Arterial Hypertension, and Restrictive Cardiomyopathy | DelveInsightThe article discusses the evolving landscape of rare cardiovascular diseases, including Giant-Cell Arteritis, Pulmonary Arterial Hypertension, and Restrictive Cardiomyopathy. It highlights the challenges in diagnosis and treatment, as well as the growing market size and pipeline of new therapies for these conditions.GlobeNewswire Inc. · Jan 14, 2025

Why CohBar Shares Are Trading Lower By 161%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionGainers CohBar, Inc. (NASDAQ: CWBR) shares jumped 161% to $4.05 after the company and Morphogenesis announced they have entered into a definitive agreement for an all-stock transaction forming a company combining expertise and resources to advance a late-stage oncology pipeline. HeartCore Enterprises, Inc. (NASDAQ: HTCR) gained 76.6% to $2.26 following better-than-expected first-quarter results. Ocean Biomedical, Inc. (NASDAQ: OCEA) shares climbed 63% to $8.57 after the company announced a patent award for novel cancer immunotherapy treatment, granted for prostate cancer, colon cancer, ovarian cancer, kidney cancer, breast cancer, glioblastoma, melanoma and lung cancer. Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) surged 44% to $1.50 after it was granted U.S. patent #11654157: Methods and compositions for cancer therapies that include delivery of halogenated thymidines and thymidine phosphorylase inhibitors in combination with radiation. Unique Fabricating, Inc. (NYSE: UFAB) climbed 32.8% to $0.2599 after the company announced an accommodation agreement and new forbearance agreement to support a restructuring or sale. Icosavax, Inc. (NASDAQ: ICVX) gained 29.7% to $10.21 after the company announced topline interim Phase 1 results for its bivalent VLP vaccine candidate IVX-A12 against RSV and hMPV in older adults. mCloud Technologies Corp. (NASDAQ: MCLD) jumped 27% to $0.4567 after the company announced it has formed a special committee for the purpose of exploring strategic alternatives. Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) gained 22.6% to $9.96. IMAC Holdings, Inc. (NASDAQ: BACK) climbed 21.9% to $0.1702. Theralink signed definitive merger agreement to be acquired by IMAC Holdings. TuSimple Holdings Inc. (NASDAQ: TSP) climbed 21.2% to $2.01. Lexaria Bioscience Corp. (NASDAQ: LEXX) climbed 20.4% to $0.83. Lexaria Bioscience recently announced it completed its HOR-A22-1 study that showed significant enhancement in the oral delivery of the estrogen hormone estradiol. PacWest Bancorp (NASDAQ: PACW) shares gained 20% to $8.23. PacWest Bancorp shares jumped around 20% on Monday after the company announced it entered into a loan purchase and sale agreement with a subsidiary of Kennedy-Wilson Holdings to sell a portfolio of ...Benzinga · May 23, 2023

Why Microvast Holdings Shares Are Trading Lower By Around 22%; Here Are 20 Stocks Moving PremarketGainers Applied UV, Inc. (NASDAQ: AUVI) shares rose 44.6% to $0.69 in pre-market trading after posting better-than-expected quarterly sales. SeqLL Inc. (NASDAQ: SQL) shares surged 34.3% to $0.5377 in pre-market trading after gaining over 19% on Monday. SeqLL recently posted a wider first-quarter loss. HeartCore Enterprises, Inc. (NASDAQ: HTCR) gained 21.1% to $1.55 in pre-market trading following better-than-expected first-quarter results. Bone Biologics Corporation (NASDAQ: BBLG) shares gained 18.8% to $0.1960 in pre-market trading after gaining over 10% on Monday. Movella Holdings Inc. (NASDAQ: MVLA) rose 18.5% to $2.28 in pre-market trading after jumping around 18% on Monday. Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) shares rose 14.4% to $1.99 in pre-market trading. The FDA recently approved expanded labeling for Cumberland Pharmaceuticals’ Caldolor, an intravenously delivered formulation of ibuprofen, to now include use in infants. Navidea Biopharmaceuticals, Inc. (NASDAQ: NAVB) shares gained 14.1% to $0.1275 in pre-market trading after the company reported the sale of preferred ...Benzinga · May 23, 2023

Red Cat Holdings And 2 Other Penny Stocks Insiders Are Aggressively BuyingThe Dow Jones settled higher by around 175 points on Friday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform. Erasca The Trade: Erasca, Inc. (NASDAQ: ERAS) Director Arthur James Bristol bought a total of 20,000 shares at an average price of $4.14. To acquire these shares, ...Benzinga · Dec 27, 2022

Newpark Resources And 2 Other Penny Stocks Insiders Are Aggressively BuyingThe Dow Jones closed higher by around 200 points on Friday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.3 Cumberland Pharmaceuticals The Trade: Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) Director Joseph C Galante bought a total of 1,625 shares ...Benzinga · Nov 21, 2022

CPIXCumberland Pharmaceuticals Inc

CPIX

Pay with—

Start Trading

Available Balance0.00

Your PositionYou don't own any CPIX yet.

Related Tickers

Earnings

Dividends

Last · Aug 3Bi-Weekly

Amount$1.50

Yield41.55%

Annual$3.00

Mkt Cap

$108.5M

Volume

85.64K

Next Earnings

November 3rd